{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:45:25Z","timestamp":1793105125893,"version":"4.5.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Papillary thyroid cancer (PTC) is the most common type of endocrine malignancy caused by genetic mutations, hormonal imbalances, and environmental factors. However, recurrent infections, and metastasis in PTC patients remain challenged due to complexity of traditional methods. Baicalein (BA) is a kind of natural flavonoid that exhibits the anti-cancer, anti-inflammatory, anti-tumor, and anti-viral activities. The molecular mechanism of baicalein in pathogenesis of PTC remains unclear. This study was designed to explore the inhibitory effects of BA against PTC by mediating the Golgi apparatus reprogramming via PLAU and suppressing the TPL2\/MEK2\/ERK2 pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Transcriptomic analysis was performed to explore the gene expression profiles. Molecular docking was employed to identify the potential targets to elucidate the molecular mechanism of action of BA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      PLAU, an up-regulated DEG, is implicated in tumor development, lymph node metastasis, and infiltration levels of neutrophils and dendritic cells in thyroid cancer patients. Molecular docking analysis revealed that serum levels of uPA protein encoded by PLAU and\n                      <jats:italic>Plau<\/jats:italic>\n                      mRNA were elevated in PTC patients with metastasis and BRAF mutation. BA treatment upregulates\n                      <jats:italic>PLAU<\/jats:italic>\n                      gene expression, but this increased PLAU protein subsequently interacts with and inhibited by BA, leading to downstream pathway suppression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>It was concluded it could be served as a promising therapeutic strategy for the treatment of PTC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1739944","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:22:56Z","timestamp":1769577776000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Baicalein inhibits the progression of thyroid cancer by suppressing the TPL2\/MEK2\/ERK2 pathway"],"prefix":"10.3389","volume":"17","author":[{"given":"Nan","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Breast and Thyroid Surgery, South China Hospital, Medical School, Shenzhen University","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, South China Hospital, Medical School, Shenzhen University","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, Shenzhen Pingle Orthopedic Hospital","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Naeem","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, South China Hospital, Medical School, Shenzhen University","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Jing","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, South China Hospital, Medical School, Shenzhen University","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-bin","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, South China Hospital, Medical School, Shenzhen University","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijian","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, South China Hospital, Medical School, Shenzhen University","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.26348","article-title":"Thyroid cancer: A review","volume":"331","author":"Boucai","year":"2024","journal-title":"Jama"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(22)00035-3","article-title":"The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020","volume":"10","author":"Pizzato","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B4","doi-asserted-by":"publisher","first-page":"101013","DOI":"10.1016\/j.drup.2023.101013","article-title":"Radioiodine-refractory differentiated thyroid cancer: Molecular mechanisms and therapeutic strategies for radioiodine resistance","volume":"72","author":"Shen","year":"2024","journal-title":"Drug Resist Updat"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00020-X","article-title":"Thyroid cancer","volume":"401","author":"Chen","year":"2023","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1038\/s41467-024-47581-1","article-title":"Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks","volume":"15","author":"Qu","year":"2024","journal-title":"Nat Commun"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2020.0330","article-title":"Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: consensus statements from the Japan association of endocrine surgery task force on management for papillary thyroid microcarcinoma","volume":"31","author":"Sugitani","year":"2021","journal-title":"Thyroid"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e1694","DOI":"10.1002\/ctm2.1694","article-title":"Targeting miR-31 represses tumourigenesis and dedifferentiation of BRAF(V600E)-associated thyroid carcinoma","volume":"14","author":"Zhang","year":"2024","journal-title":"Clin Transl Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-023-02889-y","article-title":"Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoids","volume":"43","author":"Lasolle","year":"2024","journal-title":"Oncogene"},{"key":"B10","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1210\/clinem\/dgae589","article-title":"BRAF-induced EHF expression affects TERT in aggressive papillary thyroid cancer","volume":"110","author":"Xu","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2023.0157","article-title":"Methylation-mediated silencing of ATF3 promotes thyroid cancer progression by regulating prognostic genes in the MAPK and PI3K\/AKT pathways","volume":"33","author":"Xiao","year":"2023","journal-title":"Thyroid"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2021.05.010","article-title":"RAF-MEK-ERK pathway in cancer evolution and treatment","volume":"85","author":"Ullah","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-023-01187-3","article-title":"Baicalein attenuates rotenone-induced SH-SY5Y cell apoptosis through binding to SUR1 and activating ATP-sensitive potassium channels","volume":"45","author":"Kong","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-024-01258-z","article-title":"Baicalein triggers ferroptosis in colorectal cancer cells via blocking the JAK2\/STAT3\/GPX4 axis","volume":"45","author":"Lai","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"B15","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jare.2024.02.023","article-title":"Baicalein induces apoptosis by inhibiting the glutamine-mTOR metabolic pathway in lung cancer","volume":"68","author":"Li","year":"2024","journal-title":"J Adv Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2018.33.1.121","article-title":"Combined effects of baicalein and docetaxel on apoptosis in 8505c anaplastic thyroid cancer cells via downregulation of the ERK and Akt\/mTOR pathways","volume":"33","author":"Park","year":"2018","journal-title":"Endocrinol Metab (Seoul)"},{"key":"B17","article-title":"Baicalein induced apoptosis and autophagy of undifferentiated thyroid cancer cells by the ERK\/PI3K\/Akt pathway","volume":"11","author":"Wang","year":"2019","journal-title":"Am J Transl Res"},{"key":"B18","article-title":"Baicalein suppresses the growth of the human thyroid cancer cells by inducing mitotic catastrophe, apoptosis and autophagy via NF-kB signalling pathway","volume":"25","author":"Yi","year":"2020","journal-title":"J buon"},{"key":"B19","doi-asserted-by":"publisher","first-page":"6242","DOI":"10.1038\/s41467-021-26495-2","article-title":"The serine proteases dipeptidyl-peptidase 4 and urokinase are key molecules in human and mouse scar formation","volume":"12","author":"Vorstandlechner","year":"2021","journal-title":"Nat Commun"},{"key":"B20","doi-asserted-by":"publisher","first-page":"116862","DOI":"10.1016\/j.biopha.2024.116862","article-title":"The most recent progress of baicalein in its anti-neoplastic effects and mechanisms","volume":"176","author":"Lei","year":"2024","journal-title":"BioMed Pharmacother"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abf4885","article-title":"p53 loss activates prometastatic secretory vesicle biogenesis in the Golgi","volume":"7","author":"Tan","year":"2021","journal-title":"Sci Adv"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-020-00448-z","article-title":"Current practice in patients with differentiated thyroid cancer","volume":"17","author":"Schlumberger","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","author":"Network","year":"2014","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1038\/s41467-022-29000-5","article-title":"Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat Commun"},{"key":"B25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1210\/clinem\/dgaa656","article-title":"Inhibition of BRAF sensitizes thyroid carcinoma to immunotherapy by enhancing tsMHCII-mediated immune recognition","volume":"106","author":"Zhi","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B26","doi-asserted-by":"publisher","first-page":"105387","DOI":"10.1016\/j.phrs.2020.105387","article-title":"Baicalin mediated regulation of key signaling pathways in cancer","volume":"164","author":"Singh","year":"2021","journal-title":"Pharmacol Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41420-021-00410-6","article-title":"PLAU directs conversion of fibroblasts to inflammatory cancer-associated fibroblasts, promoting esophageal squamous cell carcinoma progression via uPAR\/Akt\/NF-\u03baB\/IL8 pathway","volume":"7","author":"Fang","year":"2021","journal-title":"Cell Death Discov"},{"key":"B28","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41419-021-03960-w","article-title":"Overexpression of PSMC2 promotes the tumorigenesis and development of human breast cancer via regulating plasminogen activator urokinase (PLAU)","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"166965","DOI":"10.1016\/j.bbadis.2023.166965","article-title":"Pan-cancer analysis of PLAU indicates its potential prognostic value and correlation with neutrophil infiltration in BLCA","volume":"1870","author":"Shi","year":"2024","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13062-024-00452-7","article-title":"PLAU promotes growth and attenuates cisplatin chemosensitivity in ARID1A-depleted non-small cell lung cancer through interaction with TM4SF1","volume":"19","author":"Zheng","year":"2024","journal-title":"Biol Direct"},{"key":"B31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41389-023-00496-w","article-title":"NF-\u03baB signaling activation and roles in thyroid cancers: implication of MAP3K14\/NIK","volume":"12","author":"Cormier","year":"2023","journal-title":"Oncogenesis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13058-021-01473-0","article-title":"Fluid flow exposure promotes epithelial-to-mesenchymal transition and adhesion of breast cancer cells to endothelial cells","volume":"23","author":"Fuh","year":"2021","journal-title":"Breast Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"122868","DOI":"10.1016\/j.lfs.2024.122868","article-title":"Golgi apparatus targeted therapy in cancer: Are we there yet","volume":"352","author":"Lee","year":"2024","journal-title":"Life Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41419-024-06817-0","article-title":"Golgi dispersal in cancer stem cells promotes chemoresistance of colorectal cancer via the Golgi stress response","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e2303749","DOI":"10.1002\/adhm.202303749","article-title":"A golgi apparatus-targeted\u00a0photothermal agent with protein anchoring for enhanced cancer photothermal therapy","volume":"13","author":"Shi","year":"2024","journal-title":"Adv Healthc Mater"},{"key":"B36","doi-asserted-by":"publisher","first-page":"710","DOI":"10.3390\/cancers15030710","article-title":"MAPK pathway inhibitors in thyroid cancer: preclinical and clinical data","volume":"15","author":"Schubert","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"14385","DOI":"10.3390\/ijms232214385","article-title":"Dual inhibition of BRAF-MAPK\u00a0and STAT3 signaling pathways in resveratrol-suppressed anaplastic thyroid cancer cells with BRAF mutations","volume":"23","author":"Lu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B38","doi-asserted-by":"publisher","first-page":"0425","DOI":"10.34133\/research.0425","article-title":"Golgi protein 73 promotes angiogenesis\u00a0in hepatocellular carcinoma","volume":"7","author":"Liu","year":"2024","journal-title":"Res (Wash D C)"},{"key":"B39","doi-asserted-by":"publisher","first-page":"100805","DOI":"10.1016\/j.jbc.2021.100805","article-title":"G\u03b2\u03b3 translocation to the Golgi apparatus activates ARF1 to spatiotemporally regulate G protein-coupled receptor signaling to MAPK","volume":"296","author":"Khater","year":"2021","journal-title":"J Biol Chem"},{"key":"B40","doi-asserted-by":"publisher","first-page":"100325","DOI":"10.1016\/j.jbc.2021.100325","article-title":"G protein \u03b2\u03b3 translocation to the Golgi apparatus activates MAPK via p110\u03b3-p101 heterodimers","volume":"296","author":"Khater","year":"2021","journal-title":"J Biol Chem"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa971","article-title":"PubChem in 2021: new data content and improved web interfaces","volume":"49","author":"Kim","year":"2021","journal-title":"Nucleic Acids Res"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1739944\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:22:57Z","timestamp":1769577777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1739944\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":41,"alternative-id":["10.3389\/fendo.2026.1739944"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1739944","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"article-number":"1739944"}}